Form 4: Stitch Fix CFO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Stitch Fix's Chief Financial Officer, David Aufderhaar, sold 24,114 shares of Class A Common Stock for $5.1264 per share under a pre-arranged 10b5-1 plan.
Summary
- David Aufderhaar, Chief Financial Officer of Stitch Fix, Inc. (SFIX), disposed of 24,114 shares of Class A Common Stock.
- The transaction occurred on January 20, 2026, at a price of $5.1264 per share.
- Following this transaction, David Aufderhaar beneficially owns 1,251,862 shares of Class A Common Stock.
- The sale was executed pursuant to a Rule 10b5-1 plan, which was entered into on December 30, 2024.
Sentiment
Score: 5
Explanation: A routine insider stock sale executed under a pre-arranged 10b5-1 plan, which is a common practice for corporate executives and does not inherently signal positive or negative sentiment about the company's future.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This is a routine insider transaction disclosure, common for corporate executives managing their equity holdings. It does not inherently reflect broader industry trends or competitive positioning, as it is a pre-scheduled event under a 10b5-1 plan.
Stakeholder Impact
- Shareholders: The sale represents a minor reduction in the CFO's direct ownership, but as it's under a 10b5-1 plan, it's generally not viewed as a negative signal. The overall impact on shareholder confidence is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 12/30/2024 | Date Rule 10b5-1 plan was entered into. |
| 01/20/2026 | Date of transaction (disposal of shares). |
| 01/22/2026 | Date the Form 4 was signed. |
Recommendation
holdThe filing details a routine sale of shares by a corporate officer under a pre-arranged 10b5-1 plan. Such transactions are typically scheduled in advance to avoid accusations of insider trading and do not usually reflect a change in the officer's outlook on the company's prospects. Therefore, this specific filing alone does not provide sufficient new information to alter an existing investment thesis, warranting a 'hold' recommendation.
Keywords
Stitch Fix, SFIX, Insider Trading, Form 4, Stock Sale, CFO, David Aufderhaar, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.